Over the last 12 months, two abrdn Life Sciences Investors insiders purchased shares at market prices, about $144,000 in total, and none of them sold.
Biggest single buyer: Pittard Christian, Director, with roughly $134,000.
Zooming out by quarter: Last full quarter: net buying by insiders. Insiders bought in 2 of the last 7 full quarters. On the institutional side, 83 funds reported holding HQL at the end of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jul 20, 2026 | Mahai Chris LaVictoire | Director | Buy | 527 | $19.92 | $10K | SEC |
| Dec 18, 2025 | Pittard Christian | Director | Buy | 7,923 | $16.88 | $134K | SEC |
| Sep 23, 2025 | Saba Capital Management, L.P. | 10% Owner | Sell | 41,623 | $14.14 | $589K | SEC |
| Sep 23, 2025 | Saba Capital Management, L.P. | 10% Owner | Sell | 6,989 | $14.10 | $99K | SEC |
| Sep 19, 2025 | Saba Capital Management, L.P. | 10% Owner | Sell | 40,208 | $14.07 | $566K | SEC |
| Sep 19, 2025 | Saba Capital Management, L.P. | 10% Owner | Sell | 24,328 | $13.99 | $340K | SEC |
| Sep 17, 2025 | Saba Capital Management, L.P. | 10% Owner | Sell | 700 | $14.13 | $10K | SEC |
| Sep 17, 2025 | Saba Capital Management, L.P. | 10% Owner | Sell | 2,026 | $13.99 | $28K | SEC |
| Sep 15, 2025 | Saba Capital Management, L.P. | 10% Owner | Sell | 15,116 | $14.28 | $216K | SEC |
| Sep 4, 2025 | Weinstein Boaz | 10% Owner | Sell | 14,083 | $14.04 | $198K | SEC |
| Sep 2, 2025 | Weinstein Boaz | 10% Owner | Sell | 23,723 | $13.89 | $330K | SEC |
| Aug 27, 2025 | Saba Capital Management, L.P. | 10% Owner | Sell | 400 | $13.83 | $6K | SEC |
| Aug 25, 2025 | Saba Capital Management, L.P. | 10% Owner | Sell | 10,710 | $14.07 | $151K | SEC |
| May 22, 2025 | Weinstein Boaz | 10% Owner | Sell | 11,419 | $12.71 | $145K | SEC |
| May 19, 2025 | Weinstein Boaz | 10% Owner | Sell | 23,729 | $12.08 | $287K | SEC |
In the last 12 months abrdn Life Sciences Investors insiders made open-market purchases worth about $144,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in HQL was filed on 2026-07-20.
83 investment managers reported holding HQL in SEC Form 13F filings for Q2 2026.
No congressional trades in HQL were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).